Rezultati pretraživanja
  1. We are glad to welcome as one of our sponsors for 4th Annual Advanced Congress in London. Visit: or write to events@marketsandmarkets.com to know more about sponsorship opportunity

  2. State of the industry: The financial, clinical and scientific landscape for cell and gene therapies (Janet Lynch Lambert, CEO, ARM);

  3. prije 3 sata

    Annie Hubert, Senior Director of European Public Policy at ARM, provides an overview of the landscape in Europe at the & Innovation Summit in Berlin – slides available here:

  4. prije 4 sata

    A growing trend - Sonoma launches with a $40M Series A to advance regulatory T cell therapy in and degenerative diseases. Investors include ARCH, Milky Way, 8VC & Lyell. Notably, the CEO is Jeff Bluestone (UCSF/Parker Institute).

    Prikaži ovu nit
  5. prije 7 sati
    Odgovor korisniku/ci

    followed by and Most DEFINITELY

  6. prije 7 sati

    Now online our new work on methods for tracking products in patients.

  7. prije 14 sati

    Listen to Nkarta Therapeutics' CSO James Trager talk about the company's platform on February 18, 2020.

  8. CD19 NK- achieves 73% response rate in patients with leukemia and lymphoma

  9. prije 18 sati

    There will be a time when you just have to take a deep breath, relax, and let things go. Focus on what and who really matters to you and the rest will work itself out... I Am S.C. Yatta Follow me on Facebook Instagram and Twitter @ S.C. Yatta

  10. 4 hacks that allow you to push patient safety during cell and gene therapies to the next level. Check out our – our logistical solution for a successful CAR-T cell therapy!  _________

  11. PACT Pharma strives to expand their manufacturing operations of products, raising $75 million in their Series C financing round. Read about how they plan to develop new cell therapies that target solid tumors ==>

  12. 5. velj

    Tmunity is committed to our relentless pursuit of restoring hope for cancer patients worldwide

  13. With $315M acquisition, eyes growth in development, manufacturing:

  14. 4. velj

    All set up and ready for the next couple of days at the cell and gene therapy innovation meeting in Berlin

  15. 4. velj

    These talks have been broken up into bite-sized pieces - if you have 15-30 minutes, you can watch one of these webinars from our wonderful supply chain and logistics speakers!

  16. 4. velj
  17. 3. velj

    Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform Read more:

  18. 3. velj

    Orgenesis sells Masthercell Global, its contract development and manufacturing organisation subsidiary. Will use $127 million to continue to grow its point-of-care business and to further the development of its .

  19. 3. velj

    Register for our exclusive Bioanalysis Zone Coffee Chat focusing on developments in cell and gene therapies featuring Frontage's expert, Weiping Shao! Register, here:

  20. 30. sij

    Lineage is developing a novel to treat dry age-related macular degeneration (), the leading cause of irreversible vision loss in the US. OpRegen is currently in Phase I/IIa and has the potential to help many patients.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.